Currie Kevin S.,Lee Seung H.,Blomgren Peter A.,Kropf Jeffrey E.,Lo Jennifer R.,Mitchell Scott A.,Schmitt Aaron C.,Xiong Jin-Ming,Xu Jianjun,Zhao Zhongdong,Swaminathan Sundaramoorthi
申请号：
NZ72117514
公开号：
NZ721175A
申请日:
2014.12.22
申请国别(地区):
NZ
年份:
2017
代理人:
摘要：
The present disclosure relates to compounds that are Syk inhibitors and to their use in the treatment of various disease states, including cancer and inflammatory conditions. In particular embodiments, the structure of the compounds is given by Formula I: wherein R1, R2, R3, and R4 are as described herein. The present disclosure further provides pharmaceutical compositions that include a compound of Formula I, or pharmaceutically acceptable salts or co-crystals thereof, and methods of using these compounds and compositions to treat conditions mediated by Syk.
